Tags

Type your tag names separated by a space and hit enter

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med 2012; 157(2):120-34AIM

Abstract

DESCRIPTION

Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for prostate cancer.

METHODS

The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer, as well as the benefits and harms of treatment of localized prostate cancer.

RECOMMENDATION

The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation).This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

22801674

Citation

Moyer, Virginia A., and U.S. Preventive Services Task Force. "Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement." Annals of Internal Medicine, vol. 157, no. 2, 2012, pp. 120-34.
Moyer VA, U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-34.
Moyer, V. A. (2012). Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 157(2), pp. 120-34. doi:10.7326/0003-4819-157-2-201207170-00459.
Moyer VA, U.S. Preventive Services Task Force. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012 Jul 17;157(2):120-34. PubMed PMID: 22801674.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. AU - Moyer,Virginia A, AU - ,, PY - 2012/7/18/entrez PY - 2012/7/18/pubmed PY - 2012/9/25/medline SP - 120 EP - 34 JF - Annals of internal medicine JO - Ann. Intern. Med. VL - 157 IS - 2 N2 - DESCRIPTION: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for prostate cancer. METHODS: The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer, as well as the benefits and harms of treatment of localized prostate cancer. RECOMMENDATION: The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation).This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF. SN - 1539-3704 UR - https://www.unboundmedicine.com/medline/citation/22801674/full_citation L2 - https://www.annals.org/article.aspx?doi=10.7326/0003-4819-157-2-201207170-00459 DB - PRIME DP - Unbound Medicine ER -